Apr 14 (Reuters)- Chordia Therapeutics Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Feb 28, 2026 Feb 28, 2025 Aug 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Operating loss 662 mln loss 996 mln loss 2.01 Recurring loss 632 mln loss 975 mln loss 1.96 Net loss 633 mln loss 976 mln loss 1.96 EPS loss 8.95 yen loss 14.31 yen loss 28.41 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Chordia Therapeutics Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T